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Objectives. The purposes of this study were to investigate the
use of radial artery applanation tonometry and a generalized
transfer function for the assessment of central aortic pressure
augmentation in subjects taking commonly used antihypertensive
agents (angiotensin-converting enzyme inhibitors, beta-
adrenergic blockers, Ca21 antagonists, diuretic therapy).
Background. Applanation tonometry of the radial artery with a
generalized transfer function has been proposed as a means of
assessing central aortic blood pressure. Recently, a commercial
apparatus based on this technique has become available; we
therefore examined the effect of a generalized transfer function on
derived central aortic pressure compared with measured brachial
blood pressures and also investigated the potential of this tech-
nique to assess the influence of differing drug therapy.
Methods. Two hundred and sixty-two hypertensive patients on
stable medication were studied using the PWV Medical Blood
Pressure Analysis System (version 2, DAT-1).
Results. In univariate analysis, augmentation index showed
association with age, sex, height and heart rate. In multivariate
analysis, diastolic blood pressure and age (positively), height and
heart rate (negatively) and sex were significantly associated. After
adjustment for these variables, pressure augmentation was not
associated with any antihypertensive treatment investigated. Lin-
ear relationships were demonstrated between brachial blood
pressures and corresponding central pressures derived by trans-
fer function methods.
Conclusions. Our findings suggest that if adjustment for
central-peripheral pressure difference is necessary, simple linear
relationships may be sufficient. Age, heart rate and height but not
the class of antihypertensive medication affected the degree of
pressure augmentation observed using this technique.
(J Am Coll Cardiol 1998;32:1214–20)
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The mechanical characteristics of the systemic vasculature are
a major influence on cardiac afterload and coronary perfusion.
Indices of arterial distensibility and compliance have therefore
been proposed as a therapeutic target (1). Augmentation index
(AI) assessed in the proximal aorta is a means of quantifying
the distensibility of the aorta through the effect of mechanical
properties on the timing of the reflected pressure wave and
hence of magnitude of augmentation of central pressure. The
AI has been used to define age-related vascular changes (2,3),
to show an association of decreased pulse wave velocity (PWV)
with increasing aerobic fitness (4) and has been shown to be
associated with the presence of left ventricular hypertrophy
(5).
In view of the potential for epidemiologic and clinical use,
a number of groups have recently used the noninvasive tech-
nique of arterial applanation tonometry to obtain pressure
waveforms with a view to assessing aortic properties as deter-
mined by the AI. Initially, carotid artery applanation was used
(2–5), with Chen et al. (6) showing good approximation of
results from noninvasively determined carotid pressure wave-
forms with invasively determined central aortic waveforms.
Use of radial artery applanation with derivation of a surrogate
central aortic pressure waveform by use of a generalized
transfer function (TF) was initially reported by Karamanoglu
et al. (7). Chen et al. (8) recently found good association
between this technique (using their own TF) and results based
on directly recorded central pressure waveforms, although in
general their TF technique underestimated the derived AI
compared to the invasively recorded case.
The use of radial rather than carotid artery applanation to
obtain a pressure waveform has been proposed as preferable
on the basis that it is an easier technique and more amenable
to adequate applanation (9). The drawback of this approach
has been the established differences in temporal pressure wave
shape between the two sites; however, the recent innovation of
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the use of TF techniques borrowed from control-system engi-
neering theory is proposed to overcome this drawback.
Central pressure augmentation is dependent on the relative
timing of the arrival of the reflected pressure wave back at the
point of measurement in the aortic root within the same
cardiac cycle that generated it, and hence is related to the
mechanical stiffness of the vasculature through the PWV.
Assessment of the AI from analysis of the central aortic
pressure wave provides an indication of the degree of imped-
ance mismatch at distal reflection sites and of the magnitude of
the PWV within the thoracic and, to a lesser degree, abdominal
aorta. It provides an indication of the cardiac afterload (2) and
is fundamental to the pathogenesis of systolic hypertension
(10). Hypertension is considered to be associated with in-
creased vascular stiffness (11,12) and it is generally considered
that a less stiff systemic vasculature, associated with a lower
PWV, represents a beneficial state. A number of local neu-
roendocrine factors, including the renin-angiotensin system,
have been postulated as potentially affecting vascular stiffness
(13). Different antihypertensive agents are known to affect
arterial properties differently. Angiotensin-converting enzyme
(ACE) inhibitors and calcium channel blocking agents have
been shown to increase both brachial and central arterial
compliance (14). Beta-adrenergic blocking agents have mixed
effects and diuretic agents show little or no direct effect on
mechanical properties when used alone (15). We therefore
investigated in a cross-sectional study whether, as derived from
radial artery applanation tonometry and a generalized TF, a
discernible effect on central pressure AIs is associated with
current use of common antihypertensive treatment regimens,
in particular treatment with ACE inhibition or calcium channel
blockers. The potential for use of radial artery sphygmography
has been discussed by O’Rourke (9) and further advanced by
Chen et al. (8); however, we believe this to be the first report
of the use of a commercially available automated system (PWV
Medical Blood Pressure Analysis System, version 2, DAT-1,
PWV Medical, Sydney, Australia) in a large, unselected,
patient group. The availability of commercial systems to per-
form TF-based assessment of central AI requires further
information on at least two issues. First, does the information
obtained aid clinical decision making and, second, is a “gen-
eralized” TF applicable to the usual population of hypertensive
patients presenting for management. This report is an initial
step to addressing these questions.
Methods
Subject recruitment. All subjects were taking long-term
antihypertensive medication at the time of study and were
recruited from hospital inpatients and those attending hyper-
tension outpatient clinics at two metropolitan teaching hospi-
tals. Patients were included as they became available irrespec-
tive of therapy or concurrent medical condition, the only entry
criterion being the presence of stable antihypertensive treat-
ment. This investigation was performed in accordance with the
requirements of the Alfred Hospital and Monash Medical
Centre Human Ethics Committees.
Augmentation index was originally defined by Kelly et al.
(2) as the ratio of augmentation pressure (AP) (difference in
pressure between the early and late systolic shoulders) and
pulse pressure expressed as a percentage. In this study we have
reported values as given using the PWV Medical Blood
Pressure Analysis System. This device automates the assess-
ment of the AI as the ratio of the difference between the
pressure at the first systolic shoulder and diastolic blood
pressure (DBP) to that between DBP and the pressure at the
second inflection point (AI 5 1003(P22DBP)/(P12DBP)
(16), see Fig. 1). Although numerically different values are
obtained (including no negative values) a one-to-one mapping
occurs between the two definitions and both provide a quan-
titative expression of pressure wave contour. A quantitative
AP, defined as the pressure difference between the late and
early systolic shoulders, is also provided by automatic analysis.
In use, the PWV Medical device employs applanation tonom-
etry of the radial artery (16), with the obtained waveform
subsequently scaled from brachial artery blood pressure re-
cordings and converted to represent the central aortic pressure
wave by use of a proprietary TF relating peripheral to central
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
AI 5 augmentation index
AP 5 augmentation pressure
DBP 5 diastolic blood pressure
PWV 5 pulse wave velocity
SBP 5 systolic blood pressure
TF 5 transfer function
Figure 1. Illustration of AP and inflection points used in analysis. P1,
P2 and Pd, are the BP at the first and second shoulders and at end
diastole, respectively.
AI 5
100z~P2 2 Pd!
P1 2 Pd
, AP 5 ~P2 2 P1!.
In the current version of the PWV Medical SphygmoCor device, AI as
defined here is labeled as AIP2/P1. If the reported AI is greater than
100, then P2 . P1, that is the pressure at the second systolic shoulder,
is greater than at the first. In terms of the classification of Murgo et al.
(17), this corresponds to a type “A” waveform, whereas if P2 , P1, a
type “C” waveform results. Kelly et al. (2) calculated AI as AI 5
(P1 2 P2)/DP, that is, AP divided by pulse pressure. This formula gives
both positive and negative values of AI.
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waveforms. The AI and pressure reported are obtained from
the transformed and scaled waveform that are taken as repre-
senting the central aortic blood pressure.
Statistics. Statistical analysis was performed using SigmaStat
for Windows Version 1 (Jandel Corp., Chicago, Illinois).
Significance for group comparison and multiple regression
analysis was taken as p 5 0.05. Multiple linear regression was
performed using a forward stepwise procedure, alpha value of
0.05, with results reported as partial regression coefficients of
predictor variables. One-way analysis of variance (ANOVA)
with Student–Newman–Keuls pairwise comparison was used to
compare the characteristics of monotherapy groups. For com-
parison of treatment, only subjects on monotherapy for their
hypertension were included; all subjects were included in
correlative analyses unless otherwise specified. To allow for the
effect on AP of the known pressure dependence of vascular
compliance (18), only DBP was used in multiple regression
analysis. The reason for this is that minimum distending
pressure is a more appropriate index of pressure dependence
than either systolic blood pressure (SBP) or mean BP, which
are themselves contributed to by AP and hence are not
independent predictors.
Results
Subject characteristics. Subject inclusion was not limited
to monotherapy. Two hundred and sixty-two subjects (128
men, mean age 57 years [range 21 to 85] and 134 women, mean
age 60 years [range 26 to 84], characteristics shown in Table 1)
were assessed, of whom 121 were taking an ACE inhibitor,
106 a calcium channel blocker and 64 a beta-blocker. Eighty-
nine subjects were on monotherapy, with 14 of these taking a
beta-blocker, 33 an ACE inhibitor, 28 a calcium channel
blocker and 14 a diuretic as their only antihypertensive medi-
cation.
Univariate and multivariate associations with APs. There
was the expected close association (all subjects, n 5 262; Fig.
2) between AI and AP (r 5 0.78, p , 0.001) and also strong
association between both indices and heart rate (AI: r 5
20.33, p , 0.001; AP: r 5 20.32, p , 0.001). Significant
positive correlation was shown between augmentation param-
eters and the quantitative variables age, SBP and mean BP,
with negative association demonstrated with heart rate and
height. Augmentation parameters were also correlated with
the categorical variable sex. Results of univariate correlations
with AI for the individual treatment groups are shown in Table
2. The association of AI and heart rate and AI and DBP was
investigated separately for men and women, with results shown
in Figure 3. The significant inverse relationship between AI
and heart rate was maintained in both sexes; however, the AI
was uniformly less in men at any given heart rate while a
significant positive association between AI and DBP was found
only in the male group. Men exhibited a lower AI than women
at a given value of DBP over the range of DBP in the study. In
view of significant association among the univariate correlates,
multiple regression analysis was performed. In stepwise mul-
tiple regression, the strongest predictors were height and heart
rate (see Table 3). Sex remained a significant contributor,
along with age and DBP, but the strong association of sex and
height make differentiation of individual contribution difficult.
Inclusion of categorical treatment groups did not improve
prediction of measured central AP.
When AI was normalized for age (all subjects, n 5 262),
significant correlation with height (r 5 20.43, p , 0.001), sex
(r 5 0.31, p , 0.001) and heart rate (r 5 20.32, p , 0.001) was
maintained but association with DBP lost. In stepwise regres-
sion employing age-corrected parameters, only height and
heart rate were significant predictors of AI. For the 89 subjects
on monotherapy, ANOVA of age-corrected AI by treatment
group showed no significant difference between groups.
The lack of identified association of AI with the mono-
therapy groups was confirmed by comparison of the slope and
intercept of the individual regression lines versus age. The
numbers of subjects using only one antihypertensive medica-
tion were small in this study; however, there was no statistical
difference in either slope or intercept between the ACE
inhibitor, calcium channel blocker or diuretic groups, and
consequently these were combined in a single regression.
While the calculated regression for the beta-blocker group was
significantly different from the other three, the AI in this group
was widely scattered versus age and, in fact, tended towards an
inverse association (probably associated with lowered heart
rate; see Discussion) but did not fall outside the expected
range associated with the other treatment groups (Fig. 4). This
Table 1. Descriptive Statistics of Study Subjects and Characteristics of Monotherapy Groups
Treatment Group Number
Mean (SD)
Age
(yr)
AP
(mm Hg)
AI
(%)
Heart Rate
(min21)
Height
(cm)
SBP
(mm Hg)
DBP
(mm Hg)
ACE inhibitor 33 55 (17) 12 (11) 138 (26) 74 (11) 168 (11) 134 (23) 82 (15)
CA11 antagonist 28 60 (14) 14 (9) 140 (21) 74 (14) 168 (9) 139 (30) 82 (13)
Beta-blocker 14 64 (10) 16 (8) 144 (18) 57 (10) 168 (7) 135 (19) 76 (10)
Diuretic 14 66 (9) 14 (10) 148 (18) 71 (13) 162 (10) 134 (19) 77 (9)
All 262 59 (13) 13 (9) 137 (30) 70 (13) 167 (10) 143 (25) 80 (13)
Abbreviations: ACE inhibitor 5 angiotensin-converting enzyme inhibitor; AI 5 augmentation index; AP 5 augmentation pressure; Ca11 antagonist 5 calcium
antagonist; DBP 5 diastolic blood pressure; SBP 5 systolic blood pressure.
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study was of cross-sectional design, and assessment of AI
pretreatment was not available; however, on the basis of a
single measurement in groups of stable hypertensives, no
difference in central AI could be demonstrated between the
defined groups using the techniques described.
Comparison of measured brachial and derived central BPs.
Figure 5 shows the relationship between brachial BP measured
oscillometrically and the assigned (postransformation) values
representing central aortic pressures. The slopes of the asso-
ciation between measured peripheral and derived central
diastolic and mean BP do not differ significantly from unity;
however, the derived DBP was consistently greater than that
measured (mean difference 1.84 mm Hg, Standard Error of
Difference [SED] 0.120) while the derived mean BP was
consistently less than measured (2.62 mm Hg, SED 0.140). The
difference between derived and measured SBP increased as
measured SBP increased.
Discussion
Overall, in a large general patient group, a significant
positive univariate relationship was shown between augmenta-
tion parameters and age with a negative relationship between
AP and both height and heart rate. Association was also shown
with the categorical variable sex, which is consistent with a
previous report from London et al. (19) using manual analysis
of carotid waveforms. When analyzed by multiple regression
DBP, age (positively) and sex were related with AP while heart
rate and height retained significant negative association. Nei-
ther ACE inhibition nor any of the other forms of treatment
investigated was associated with the degree of AP observed
when adjusted for the confounding effects of heart rate, age
and other covariates. Although the ACE inhibitor mono-
therapy group was younger than the remaining monotherapy
subjects (analysis of variance), there were no significant pair-
wise differences and, in fact, comparison with a younger group
would tend to increase a drug-dependent association rather
than obscure it. The number of subjects on monotherapy in
this study was small and whether our cross-sectional findings
associated with individual drug groups are representative of
larger clinical usage may require further prospective study.
Mechanisms. It is clear from consideration of the mecha-
nism involved that a reflected pressure wave returning to the
aortic root earlier in the cardiac cycle will be associated with
Figure 2. Univariate association (95% confidence interval of
the line and 95% prediction interval) of AI and AP with
heart rate and age.
Table 2. Univariate Correlation of Augmentation Index (Correlation Coefficient, p Value)
Treatment
Heart Rate
(min21)
DBP
(mm Hg)
SBP
(mm Hg)
Height
(cm)
Age
(yr)
ACE inhibitor 20.55, ,0.001 0.08, 0.68 0.58, ,0.001 20.63, ,0.001 0.32, 0.07
Ca11 antagonist 20.48, 0.02 20.01, 0.99 0.23, 0.27 20.42, 0.04 0.32, 0.12
Beta-blocker 0.22, 0.45 0.50, 0.07 0.25, 0.39 20.55, 0.05 20.24, 0.41
Diuretic 20.28, 0.35 0.22, 0.47 0.68, 0.01 20.215, 0.50 0.28, 0.36
All subjects 20.33, ,0.001 0.09, 0.14 0.27, ,0.001 20.34, ,0.001 0.26, ,0.001
Abbreviations as in Table 1.
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greater augmentation of central aortic pressure than if return
is delayed until later in systole or early in diastole. Earlier
return is associated with a slower heart rate, an increased PWV
at a given heart rate or with a lesser distance of travel to and
from principle reflection sites. The unifying thread in these
mechanisms is the underlying dependence of AP on duration
of the cardiac cycle and pressure PWV. As with all other
mechanical indices reported, our results clearly show the
association of AP with aging, presumably acting through the
accepted association of increased vascular stiffness with in-
creased PWV. These results also suggest that this dependence
may be different for men and women but, importantly, high-
light the dependence of the measurement on height and
underlying heart rate.
The validity of the TF in arterial measurement depends not
only on the applicability of the method in general but also on
the specific function adopted. As yet, the two TFs reported for
radial to central transfer have been obtained from relatively
small numbers of subjects [14 subjects (7) and 16 subjects (8)].
In the case of the device used in this study, the TF is based on
results obtained from normotensive subjects undergoing inva-
sive procedures for presumptive coronary heart disease and it
is yet to be established whether generalized TFs obtained in a
particular patient group are applicable over a wide range of
patient types.
This is the first reported use of a commercially available
device for the measurement of augmentation parameters. We
therefore looked in detail at the manner in which the periph-
eral to central transformation affects the outcome. Mean BP
does not vary in the large conduit arteries and transformed
results obtained were consistent with this fact. Systolic blood
pressure is amplified with peripheral progression but the
magnitude and significance of the effect between brachial and
central aortic pressures is disputed (12,20–22). In the current
study, the differences in mean and diastolic BP fall within the
range of measurement resolution and are inconsequential. The
Figure 4. Combined regression line for the ACE inhibitor, calcium
channel blocker and diuretic groups (95% confidence and prediction
intervals shown) with beta-blocker group (solid circles) superimposed.
Table 3. Partial Regression Coefficients (All Subjects, n 5 262) for
Forward Stepwise Linear Regression for Dependent Variables
Augmentation Pressure and Augmentation Index*
Forward Stepwise Linear Regression
Partial Regression
Coefficient
Partial Regression
Coefficient
Predictor variable AP AI
Constant 33.37 221.34
Age (yr) 0.22 0.34
Sex 4.32 10.68
Diastolic BP (mm Hg) 0.22 0.48
Heart rate (min21) 20.29 20.83
Height (cm) 20.22 20.59
*All p values ,0.01. AI 5 Augmentation index; AP 5 augmentation
pressure; BP 5 blood pressure.
Figure 3. Linear regression of central aortic AI with heart rate (top
panel) and DBP (lower panel) for males (solid circle, dashed line) and
females (open circle, solid line) analyzed separately. The regression
equations are: AI (males) 5 179.37 2 0.73 3 (HR), (r2 5 0.134, p 5
0.000); AI (females) 5 198.70 2 0.74 3 (HR), (r2 5 0.159, p 5 0.000);
AI (males) 5 93.02 1 0.45 3 (DBP), (r2 5 0.034, p 5 0.04); AI
(females) versus DBP, (r2 5 0.002, nonsignificant).
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strong relationship between derived and measured SBP im-
plies that, in the practical case, equivalent results may be
obtained by assessment of the pressure waveform from the
carotid or subclavian artery with use of directly measured
brachial pressures adjusted, if necessary, using the linear
regression equation obtained. This would obviate the need for
waveform transformation. Alternatively, SBP may be dis-
pensed with entirely, and the carotid pressure waveform scaled
by linear interpolation using the brachial DBP and mean BP
values (3,23). Also, since there is clear association between AP
and the dimensionless AI, use of AI (2,4) may be preferable as
numerical scaling is not required. In this case the benefit of use
of the radial artery relies solely on the ease of applanation, a
factor which may be significant if ambulatory techniques
become available.
Generalized TF. In the system used, the scaled and trans-
formed central pressure waveform is obtained via passage of
the radial waveform through a proprietary TF. Using differing
techniques, both Karamanoglu et al. (7) and Chen et al. (8)
found very similar generalized TFs. Although neither group of
authors provided the precise mathematical form of their TF,
the PWV Medical device relies on the technique and validation
studies described by Karamanoglu et al. (7) as the basis of its
procedure. Theoretically, use of TF techniques require a
linear, time-invariant system (24). The basic transmission
parameters of the vasculature (pressure–volume relationship)
are accepted as nonlinear, and by definition time invariance is
negated by any effective intervention, including non–steady-
state drug therapy. Since by definition a generalized TF is
applied to all subjects, this would appear to be inconsistent
with the TF approach; however, the magnitude of the effect of
this assumption is unknown and cannot be determined by the
current study. As discussed by Chen et al. (8), the assumption
of a uniform TF may be tenable in certain instances—for
example, in assessing group responses—but it must be care-
fully considered when assessing individual responses, and
further work is required here. Interventions that differentially
affect the more muscular brachioradial compared to the elastic
aorta may also affect the applicability of a generalized TF.
Effect of heart rate on AP. The dominant variables in
analysis of augmentation parameters in this study were height
and heart rate. In comparison studies, therefore, it would be
necessary to adjust for height as well as any variation in heart
rate at the times of assessment. In general, women might be
Figure 5. Upper three panels, comparison of derived central pressures
versus measured brachial pressures. Lower three panels, error plots
(mean difference and 95% confidence intervals) of the comparisons.
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expected to have lower PWVs than men of similar age; despite
this, AI at any given heart rate or DBP was greater in women
compared to men (see Fig. 3). The likely explanation for these
differences is the decreased distance of travel to the principle
reflecting site in women due to their relatively shorter stature.
It may therefore also be necessary to control for significant
height differences in future studies using augmentation param-
eters.
Conclusions. Assessment of pressure augmentation using
the technique described is noninvasive and a relatively easy
measurement to perform. In this study, the increase in AI with
age has been confirmed. The major new findings arising from
the present study were the heart rate dependence of AI and
the close linear association between brachial and central BPs
as assessed by the generalized TF. Also of interest was the lack
of discrimination of AI by class of antihypertensive therapy.
Although it is now generally accepted that particular antihy-
pertensive classes, especially the ACE inhibitors, have benefi-
cial effects on muscular arterial mechanical properties, as well
as lowering BP, a differential effect was not able to be
demonstrated in this study using radial artery applanation.
Whether this is a real lack of antihypertensive drug class effect
on change in arterial function as seen at the level of the central
aorta, or a limitation of radial applanation tonometry for the
use proposed, or of the cross-sectional nature of the study
could not be determined. To resolve the presence or absence
of a true drug effect would require a prospective controlled
study and would require invasive studies, negating the pro-
posed benefit of noninvasive applanation tonometry.
Summary. Derivation of central AI via radial artery
tonometry is a relatively simple, noninvasive procedure for
which a commercial device is available. In the present study, we
were not able to demonstrate that use of a generalized TF
altered practical assessment of central aortic BP, nor could we
demonstrate any difference in the age-related dependence of
derived AP due to the common antihypertensive drug classes.
Further studies are required to ascertain the clinical place of
measurement of augmentation parameters and the use of
radial artery applanation.
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